125 related articles for article (PubMed ID: 23271361)
1. Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk.
Jiang H; Lin Y; Yang CQ; Li Q; Luo J; Zhou Y; Xue J; Wei W; Gao Y
Tumour Biol; 2013 Apr; 34(2):779-85. PubMed ID: 23271361
[TBL] [Abstract][Full Text] [Related]
2. Association between the XRCC6 Promoter rs2267437 polymorphism and cancer risk: evidence based on the current literature.
Xu H; Zou P; Chen P; Zhao L; Zhao P; Lu A
Genet Test Mol Biomarkers; 2013 Aug; 17(8):607-14. PubMed ID: 23745766
[TBL] [Abstract][Full Text] [Related]
3. Association of XRCC6 C1310G and LIG4 T9I polymorphisms of NHEJ DNA repair pathway with risk of colorectal cancer in the Polish population.
Balinska K; Wilk D; Filipek B; Mik M; Zelga P; Skubel P; Dziki Ł; Dziki A; Mucha B; Kabziński J; Majsterek I
Pol Przegl Chir; 2019 Mar; 91(3):15-20. PubMed ID: 31243170
[TBL] [Abstract][Full Text] [Related]
4. Association of DNA double-strand break gene XRCC6 genotypes and lung cancer in Taiwan.
Hsia TC; Liu CJ; Chu CC; Hang LW; Chang WS; Tsai CW; Wu CI; Lien CS; Liao WL; Ho CY; Bau DT
Anticancer Res; 2012 Mar; 32(3):1015-20. PubMed ID: 22399625
[TBL] [Abstract][Full Text] [Related]
5. Association between the Ku70-1310C/G promoter polymorphism and cancer risk: a meta-analysis.
Xu L; Ju XB; Li P; Wang J; Shi ZM; Zheng MJ; Xue DD; Xu YJ; Yin YM; Wang S; You YP
Asian Pac J Cancer Prev; 2012; 13(2):683-7. PubMed ID: 22524845
[TBL] [Abstract][Full Text] [Related]
6. Association between the XRCC6 polymorphisms and cancer risks: a systematic review and meta-analysis.
Jia J; Ren J; Yan D; Xiao L; Sun R
Medicine (Baltimore); 2015 Jan; 94(1):e283. PubMed ID: 25569644
[TBL] [Abstract][Full Text] [Related]
7. Association between XRCC5, 6 and 7 gene polymorphisms and the risk of breast cancer: a HuGE review and meta-analysis.
Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
Asian Pac J Cancer Prev; 2012; 13(8):3637-43. PubMed ID: 23098447
[TBL] [Abstract][Full Text] [Related]
8. The contribution of XRCC6/Ku70 to hepatocellular carcinoma in Taiwan.
Hsu CM; Yang MD; Chang WS; Jeng LB; Lee MH; Lu MC; Chang SC; Tsai CW; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):529-35. PubMed ID: 23393345
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism C-1310G in the promoter region of Ku70/XRCC6 is associated with risk of renal cell carcinoma.
Wang W; Pan X; Huo X; Yan F; Wang M; Wang D; Gao Y; Cao Q; Luo D; Qin C; Yin C; Zhang Z
Mol Carcinog; 2012 Oct; 51 Suppl 1():E183-90. PubMed ID: 22593040
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma.
Li R; Yang Y; An Y; Zhou Y; Liu Y; Yu Q; Lu D; Wang H; Jin L; Zhou W; Qian J; Shugart YY
Carcinogenesis; 2011 Apr; 32(4):530-6. PubMed ID: 21304054
[TBL] [Abstract][Full Text] [Related]
11. The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.
Chang WS; Ke HL; Tsai CW; Lien CS; Liao WL; Lin HH; Lee MH; Wu HC; Chang CH; Chen CC; Lee HZ; Bau DT
Anticancer Res; 2012 Sep; 32(9):3855-60. PubMed ID: 22993329
[TBL] [Abstract][Full Text] [Related]
12. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):28-34. PubMed ID: 26754263
[TBL] [Abstract][Full Text] [Related]
13. Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.
Tian X; Tian Y; Ma P; Sui C; Meng F; Li Y; Fu L; Jiang T; Wang Y; Jiang Y
Tumour Biol; 2013 Oct; 34(5):2589-97. PubMed ID: 23749486
[TBL] [Abstract][Full Text] [Related]
14. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.
Wang Z; Zhang W
Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553
[TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms at promoters of XRCC5 and XRCC6 genes and risk of breast cancer.
Rajaei M; Saadat I; Omidvari S; Saadat M
Med Oncol; 2014 Apr; 31(4):885. PubMed ID: 24615008
[TBL] [Abstract][Full Text] [Related]
16. Association of X-ray repair cross-complementing-6 genotypes with childhood leukemia.
Pei JS; Lee YM; Lo HH; Hsu YN; Lin SS; Bau DT
Anticancer Res; 2013 Dec; 33(12):5395-9. PubMed ID: 24324074
[TBL] [Abstract][Full Text] [Related]
17. Association Between Functional Polymorphisms of DNA Double-Strand Breaks in Repair Genes XRCC5, XRCC6 and XRCC7 with the Risk of Systemic Lupus Erythematosus in South East Iran.
Jahantigh D; Salimi S; Mousavi M; Moossavi M; Mohammadoo-Khorasani M; Narooei-nejad M; Sandoughi M
DNA Cell Biol; 2015 May; 34(5):360-6. PubMed ID: 25756210
[TBL] [Abstract][Full Text] [Related]
18. The role of XRCC6/Ku70 in nasopharyngeal carcinoma.
Huang CY; Tsai CW; Hsu CM; Shih LC; Chang WS; Shui HA; Bau DT
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1480-5. PubMed ID: 26149939
[TBL] [Abstract][Full Text] [Related]
19. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies.
Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X
J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Macrophage Migration Inhibitory Factor -173G/C Gene Polymorphism to the Risk of Cancer in Chinese Population.
Wang CD; Li TM; Ren ZJ; Ji YL; Zhi LS
Asian Pac J Cancer Prev; 2015; 16(11):4597-601. PubMed ID: 26107210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
